A multicenter study to examine clinical scenarios for long-term monitoring of epileptic seizures with a wearable biopotential technology - SeizeIT2

Department of Neurology, UZ Leuven0 sites495 target enrollmentAugust 5, 2021

Overview

No summary available.

Registry

who.int

Start Date

August 5, 2021

End Date

June 30, 2022

Last Updated

last year

Study Type

Interventional

Sex

All

Sponsor

Department of Neurology, UZ Leuven

•1\.Adults (\>18 years old) who have given informed consent. Adults unable to provide consent or illiterate individuals can participate provided a caregiver or proxy can give informed consent.
•2\.Children (4\-18 years old), if a parent can provide consent.
•3\.Refractory epilepsy, including refractory idiopathic absence epilepsy with typical absences (childhood absence or juvenile absence epilepsy)
•4\.Patients with focal epilepsy, who will undergo a presurgical evaluation

•1\.Inability to provide written informed consent, either directly or via a guardian.
•2\.Known allergy to electrodes used as part of the study protocol.
•3\.Having an implanted device, including (but not limited to) a pacemaker, cardioverter defibrillator (ICD), and/or neural stimulation device
•4\.Any other condition or finding that would compromise the safety of the participant or the quality of the study data, or otherwise interfere with achieving the study objectives, as determined by the investigator or research coordinator.
•5\.Pregnant women, neonates, employees or students of the participating enrolment centres, prisoners, and individuals whose first language is not English or that of the host country.